|
Dr. Stevens leads its interdisciplinary teams with an uncompromising emphasis on excellence in science and client service. During her outstanding career, she has served in a clinical directorship role (Phases I-IV) for a major pharmaceutical company focusing on women�s health and hormone replacement therapy products, and as director of pharmacokinetics and pharmacodynamics for a life sciences firm. At the U.S. Food and Drug Administration (FDA), Dr. Stevens held positions as a pharmacokinetic reviewer and a team leader in the Office of Clinical Pharmacology and Biopharmaceutics in the Center for Drug Evaluation and Research (CDER). While at the FDA, she reviewed and supervised the reviews of anti-infectives, analgesics, anti-inflammatories, drugs of abuse, anesthetics, nuclear medicine and radiopharmaceutical drug products. Dr. Stevens earned her PhD in biopharmaceutics/pharmacokinetics from Oregon State University, and serves as an adjunct associate professor of pharmacokinetics at the University of Cincinnati. Author of more than 40 abstracts/ publications, she has been an invited speaker nationally and internationally. | 